Recent Patents on Anti-Infective Drug Discovery
Volume 15, 3 Issues, 2020
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
Order Your Article Before Print
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research
Contents
Recent Patents on Anti-Infective Drug Discovery, Volume 9 - Number 2
Recent Developments in Anti-dotes Against Anthrax
, 9(2): 83 - 96Neha Dhasmana, Lalit K. Singh, Asani Bhaduri, Richa Misra and Yogendra Singh
DOI: 10.2174/1574891X09666140830213925
Recent Developments in Anti-dotes Against Anthrax
Current Status of Chemically Synthesized Inhibitors of Ebola Virus
, 9(2): 97 - 103Anthony P. Cardile, Douglas L. Mayers and Sina Bavari
DOI: 10.2174/1574891X10666150326114221
Current Status of Chemically Synthesized Inhibitors of Ebola Virus
Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis
, 9(2): 104 - 111Rashi Chauhan, Gulshan Wadhwa, Sanjeev K. Sharma and Chakresh K. Jain
DOI: 10.2174/1574891X09666141114222644
Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis
New Perspectives of HIV/AIDS Therapy Study
, 9(2): 112 - 120Da-Yong Lu, Ting-Ren Lu, Jin-Yu Che, Hong-Ying Wu and Bin Xu
DOI: 10.2174/1574891X10666150109115402
New Perspectives of HIV/AIDS Therapy Study
Cancer Targeted Magic Bullets for Effective Treatment of Cancer
, 9(2): 121 - 135Preeti Aneja, Mahfoozur Rahman, Sarwar Beg, Shivali Aneja, Vishal Dhingra and Rupali Chugh
DOI: 10.2174/1574891X10666150415120506
Cancer Targeted Magic Bullets for Effective Treatment of Cancer
Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
, 9(2): 136 - 143Sasmita Biswal
DOI: 10.2174/1574891X10666150408153356
Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
Evaluation of Urinary Interleukin-8 Levels in Patients with Spinal Cord Injury
, 9(2): 144 - 149Monireh Rahimkhani, Alireza Mordadi, Sajad Varmazyar and Ali Tavakoli
DOI: 10.2174/1574891X10666150310152532
Opinion Paper: Pharmacogenomics Testing for Type B Adverse Drug Reactions to Anti- Infective Drugs: The Example of Hypersensitivity to Abacavir
, 9(2): 151José A.G. Agúndez, Gara Esguevillas, Gemma Amo and Elena García-Martín
DOI: 10.2174/1574891X10666150416130637
Editor-in-Chief
Dieter Kabelitz
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105
(Germany)
Biography
View Full Editorial Board
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105
Biography
Biography of Dieter Kabelitz
Dieter Kabelitz is full professor at the University of Kiel, Germany, and Director of the Institute of Immunology. Previously, he was Head oft he Department of Immunology at the Paul-Ehrlich-Institute, Langen/Germany, and Associate Professor at the University of Heidelberg/Germany. Prof. Kabelitz has more than 30 years of research experience in immunology, with a strong focus on the functional analysis of human T lymphocytes. He has published more than 340 papers in peer-reviewed journals and edited or co-edited several books
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Infective Drug Discovery was launched in 2006. Dr. Dieter Kabelitz serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.10
New eBook
 |
Frontiers in Clinical Drug Research-Anti InfectivesYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net